Cooper Maroc in Consumer Health (Morocco)

March 2015 | 2 pages | ID: CC6A63B8938EN
Euromonitor International Ltd

Abstracts

As one of the active companies in terms of innovation, Cooper Pharma will continue its research and development by launching new products mainly in key mature categories of analgesics, digestive remedies and cough, cold and allergy remedies, which are the big contributors to consumer health sales. The company will also invest in fast growing categories, such as vitamins and dietary supplements and sports nutrition.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric OTC Healthcare, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Cooper Pharma: Key Facts
Summary 2 Cooper Pharma: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Cooper Pharma: Competitive Position 2014